HIV

All articles by HIV

Five things for pharma marketers to know: Monday, June 12, 2017
Five things for pharma marketers to know: Monday, June 12, 2017
Virginia Lau
June 12, 2017
2:38 pm

Teva gets FDA approval for Truvada generic; the FDA rejects Coherus’ Neulasta biosimilar; only 17% of Americans find health industries to be innovative

Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval
Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval
Jaimy Lee
May 3, 2017
2:40 pm

The drugmaker is is using Tumblr, Snapchat, and YouTube as well as gay dating apps like Grindr to promote its HIV prevention pill.

Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Jaimy Lee
February 8, 2017
3:55 pm

The drugmaker is planning a commercial boost for its HIV-prevention drug.

Gilead’s Meyers on making deals and finding unmet patient needs
Gilead’s Meyers on making deals and finding unmet patient needs
Virginia Lau
November 29, 2016
3:19 pm

The drugmaker’s new EVP of worldwide commercial operations also talks about tackling medication access, product launches, and starting a commercial team from scratch.

FCB Health’s Rich Levy on HIV/AIDS Campaigns that Fight Stigma
FCB Health’s Rich Levy on HIV/AIDS Campaigns that Fight Stigma
Rich Levy, FCB Health
October 18, 2016
1:45 pm

Here are four campaigns that that help raise awareness of HIV treatment and alter prejudices.

How five therapies changed the course of pharma history
How five therapies changed the course of pharma history
Marc Iskowitz
October 3, 2016
9:00 am

And why the stories behind thalidomide, Naprosyn, AZT, cardiology stents, and Zaltrap still resonate.

ViiV Healthcare hires Porter Novelli for corporate comms
ViiV Healthcare hires Porter Novelli for corporate comms
Anna Reynolds
August 13, 2015
8:15 pm

ViiV Healthcare, a joint venture by Pfizer and GlaxoSmithKline, has appointed Porter Novelli to manage its corporate comms account, PRWeek understands.

Five things for pharma marketers to know: Friday, August 7
Five things for pharma marketers to know: Friday, August 7
Jaimy Lee
August 7, 2015
3:00 pm

CVS excludes 31 drugs including Viagra from its 2016 formulary; Sanofi partners with Evotec on stem-cell treatment development; primary-care physicians may hesitate to prescribe Truvada for PrEP

Five things for pharma marketers to know: Monday, August 3
Five things for pharma marketers to know: Monday, August 3
Kevin McCaffrey
August 3, 2015
3:00 pm

Shire buys Foresight Biotherapeutics for $300 million; Novartis sold off three investigational drugs into Mereo BioPharma; new blood thinners linked to 8,000 deaths since 2010

Five things for pharma marketers to know: Wednesday, February 18
Five things for pharma marketers to know: Wednesday, February 18
Deborah Weinstein
February 18, 2015
3:30 pm

Researchers find repeat marketing offenders in the UK and Sweden, Actavis plans to take Allergan’s name and Sanofi enters an auto-immune disease collaboration.

  • From Our Partners